Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Cited by other online articles
Google Scholar
Right arrow Articles by Doraiswamy, P. M.
Right arrow Articles by Clary, C. M.
Right arrow Articles citing this Article
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doraiswamy, P. M.
Right arrow Articles by Clary, C. M.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58:M1137-M1144 (2003)
© 2003 The Gerontological Society of America

Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?

P. Murali Doraiswamy1, K. Ranga Rama Krishnan1, Thomas Oxman2, Lawrence R. Jenkyn2, David J. Coffey2, Tal Burt3 and Cathryn M. Clary3

1 Departments of Psychiatry and Medicine, Duke University Medical Center, Durham, North Carolina.
2 Dartmouth Medical School, Lebanon, New Hampshire.
3 Pfizer, Inc., New York, New York.

Objectives. To analyze the effects of antidepressants on cognitive functioning in elderly depression.

Methods. Data were pooled for elderly participants with major depression from two double-blind 12-week studies (n = 444) comparing sertraline to fluoxetine and to nortriptyline. A cognitive battery was performed pre-treatment and post-treatment that included the Shopping List Task (SLT), which quantifies short-term and long-term memory storage and retrieval, and the Digit Symbol Substitution Test (DSST), which measures visual tracking, motor performance, and coding.

Results.Older age, male gender, higher systolic blood pressure, and higher illness severity were associated with lower performance on specific cognitive measures at baseline. For the entire group, improved depression and a lower anticholinergic side effect (dry mouth and constipation) severity were associated with statistically significant improvement in the SLT and DSST. The correlations between improvements in depression and improvement in tested cognitive function were highest for sertraline followed by nortriptyline and then fluoxetine.

Conclusions. Acute improvement in depression is associated with cognitive improvement as measured by the SLT and DSST. Prospective studies are warranted to study the effects of potential differences among antidepressant therapies on long-term cognitive outcomes in geriatric depression.




This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)


Home page
Ann PharmacotherHome page
C. L Raehl, C. Bond, T. J Woods, R. A Patry, and R. B Sleeper
Screening Tests for Intended Medication Adherence Among the Elderly
Ann. Pharmacother., May 1, 2006; 40(5): 888 - 893.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2003 by The Gerontological Society of America.